Biomaxima (944.F) traded down -0.81 % during a 24 hours period ending at 10:09 PM Central Europe on Tuesday 27th. One Biomaxima stock can currently be bought for about PLN 9.75 on popular exchanges. Current supply of Biomaxima stocks is 4.2 mn. Biomaxima has a current market capitalization of PLN 40.8 mn and approximately PLN 18.8 k worth of Biomaxima was traded on exchanges in the last 24 hours. Since last month end, Biomaxima has traded -2.4 % down. Simple moving average of last 200 days is at PLN 10.87. The highest price of past 52 weeks was recorded at PLN 13.25 on 01/29/2026. 52 weeks low was at PLN 9.21 on 07/10/2026.

Here is how related stocks have performed in the past 24 hours:

  • Letus Capital (7I4.F) traded up 6.77 % and now trades at EUR 0.07. Letus Capital has a market capitalisation of EUR 5.9 mn.

  • Medapp (WQ1.F) traded down -0.29 % and now trades at PLN 0.17. Medapp has a market capitalisation of PLN 42.8 mn. Current price/earnings ratio for Medapp is 341.

  • Figene Capital (Figene Capital) traded flat 0 % and now trades at PLN 0.49. Current market capitalisation for Figene Capital is PLN 28.6 mn.

  • Rocca (82J.F) traded down -0.7 % and now trades at EUR 0.56. Rocca has a market capitalisation of EUR 5.9 mn.

  • Mpay (8NJ.F) traded up 2.3 % and now trades at PLN 0.31. Current market capitalisation for Mpay is PLN 25.5 mn.

About Biomaxima

BioMaxima SA is a health care equipment and supply company based in Poland. The company manufactures and distributes reagents for in vitro diagnostics, with its primary products including diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. Additionally, the company provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. BioMaxima SA supplies its products to approximately 2,000 laboratories in Poland and also exports in the international markets. The company was founded in 2002 and is located in Lublin, Poland. The website for the company is www.biomaxima.com , and it trades on the Warsaw Stock Exchange.